What's new in the field of prostate cancer chemoprevention?
Related Experiment Video
Updated: Aug 18, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Kanwaljit Mahal1, Javier Hernandez, Joseph W Basler
1Division of Urology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
Abstract:
Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.
Insights
Chemoprevention strategies are being explored for various cancers. This review focuses on prostate cancer chemoprevention trials, including the Prostate Cancer Prevention Trial and the Selenium and Vitamin E Cancer Prevention Trial.
Area of Science:
- Oncology
- Preventive Medicine
Background:
- Prostate cancer is a leading malignancy, prompting significant research into preventive strategies.
- Chemoprevention offers a promising approach to reduce cancer incidence and mortality.
Purpose of the Study:
- To review current and ongoing chemoprevention trials for prostate cancer.
- To discuss key trials such as the Prostate Cancer Prevention Trial and the Selenium and Vitamin E Cancer Prevention Trial.
- To explore the role of cyclooxygenase inhibitors in prostate cancer prevention.
Main Methods:
- Review of completed, planned, and underway chemoprevention trials.
- Analysis of data from landmark studies in prostate cancer prevention.
- Examination of pharmacological agents, including cyclooxygenase inhibitors.
Main Results:
- Chemoprevention trials for prostate cancer are actively being conducted.
- Specific trials like the Prostate Cancer Prevention Trial and the Selenium and Vitamin E Cancer Prevention Trial provide valuable insights.
- Cyclooxygenase inhibitors are under investigation for their preventive potential.
Conclusions:
- Chemoprevention represents a critical area of research for managing prostate cancer.
- Further investigation into agents like selenium, vitamin E, and cyclooxygenase inhibitors is warranted.
- Successful chemoprevention could significantly impact prostate cancer rates.
Related Concept Videos
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
